KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Work In Process (2017 - 2023)

Biolife Solutions (BLFS) has disclosed Work In Process for 8 consecutive years, with $6.9 million as the latest value for Q1 2023.

  • Quarterly Work In Process rose 38.54% to $6.9 million in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $6.9 million through Mar 2023, up 38.54% year-over-year, with the annual reading at $5.7 million for FY2022, 13.26% up from the prior year.
  • Work In Process for Q1 2023 was $6.9 million at Biolife Solutions, up from $5.7 million in the prior quarter.
  • The five-year high for Work In Process was $6.9 million in Q1 2023, with the low at $275000.0 in Q2 2019.
  • Average Work In Process over 5 years is $3.3 million, with a median of $3.2 million recorded in 2020.
  • The sharpest move saw Work In Process tumbled 50.54% in 2019, then surged 510.18% in 2020.
  • Over 5 years, Work In Process stood at $1.9 million in 2019, then grew by 5.8% to $2.0 million in 2020, then skyrocketed by 150.0% to $5.0 million in 2021, then grew by 13.26% to $5.7 million in 2022, then grew by 22.08% to $6.9 million in 2023.
  • According to Business Quant data, Work In Process over the past three periods came in at $6.9 million, $5.7 million, and $5.5 million for Q1 2023, Q4 2022, and Q3 2022 respectively.